Compounds > 3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol
Page last updated: 2024-11-04

3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol and Dyskinesia, Medication-Induced

3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol has been researched along with Dyskinesia, Medication-Induced in 2 studies

3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol: RN given refers to (+/-)-isomer; RN, RRs & structure given in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cote, SR1
Chitravanshi, VC1
Bleickardt, C1
Sapru, HN1
Kuzhikandathil, EV1
Canales, JJ1
Iversen, SD1

Other Studies

2 other studies available for 3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol and Dyskinesia, Medication-Induced

ArticleYear
Overexpression of the dopamine D3 receptor in the rat dorsal striatum induces dyskinetic behaviors.
    Behavioural brain research, 2014, Apr-15, Volume: 263

    Topics: Animals; Antiparkinson Agents; Benserazide; Benzopyrans; Corpus Striatum; Dependovirus; Dopamine; Do

2014
Dynamic dopamine receptor interactions in the core and shell of nucleus accumbens differentially coordinate the expression of unconditioned motor behaviors.
    Synapse (New York, N.Y.), 2000, Jun-15, Volume: 36, Issue:4

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzopyrans;

2000